These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21057957)

  • 1. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
    Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
    Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
    Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
    Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of MIB-1, p53, epidermal growth factor receptor, and INI1 in childhood chordomas.
    Yadav R; Sharma MC; Malgulwar PB; Pathak P; Sigamani E; Suri V; Sarkar C; Kumar A; Singh M; Sharma BS; Garg A; Bakhshi S; Faruq M
    Neuro Oncol; 2014 Mar; 16(3):372-81. PubMed ID: 24305715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis.
    Antonelli M; Raso A; Mascelli S; Gessi M; Nozza P; Coli A; Gardiman MP; Arcella A; Massimino M; Buttarelli FR; Giangaspero F
    Am J Surg Pathol; 2017 Jan; 41(1):56-61. PubMed ID: 27635948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poorly differentiated chordoma showing loss of SMARCB1/INI1: Clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity.
    Rekhi B; Michal M; Ergen FB; Roy P; Puls F; Haugland HK; Soylemezoglu F; Kosemehmetoglu K
    Ann Diagn Pathol; 2021 Dec; 55():151809. PubMed ID: 34482218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Poorly-differentiated chordoma with INI1 loss: a clinicopathologic study].
    Feng JY; Chen L; Ma YY; Yang HW; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):695-698. PubMed ID: 29050071
    [No Abstract]   [Full Text] [Related]  

  • 7. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor.
    Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y
    Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated chordoma with loss of SMARCB1/INI1 expression in pediatric patients: A report of two cases and review of the literature.
    Cha YJ; Hong CK; Kim DS; Lee SK; Park HJ; Kim SH
    Neuropathology; 2018 Feb; 38(1):47-53. PubMed ID: 28812319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly differentiated SMARCB1/INI1-negative chordomas.
    Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H
    Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report.
    Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
    Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
    [No Abstract]   [Full Text] [Related]  

  • 12. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity.
    Tsai CY; Wong TT; Lee YH; Chao ME; Lin SC; Liu DJ; Liang ML; Wang HW; Ho DM
    Am J Surg Pathol; 2012 Jan; 36(1):128-33. PubMed ID: 22020042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
    Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
    Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
    Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
    Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.
    Owosho AA; Zhang L; Rosenblum MK; Antonescu CR
    Genes Chromosomes Cancer; 2018 Feb; 57(2):89-95. PubMed ID: 29119645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.
    Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O
    J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.